Dr. Alan Miller on Benefits of Liquid Biopsy

Alan M. Miller, MD, PhD
Published: Wednesday, Apr 29, 2015



Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System discusses the benefits of liquid biopsy.

By dissecting the tumor molecularly and cellularly it can be determined what makes that tumor unique. Those unique factors can then be followed in the blood or the urine, providing critical information without going back into the tumor, says Miller.

This makes it easier to tell if the tumor is responding, allowing changes in treatment to be made right away if it is not. Liquid biopsy can also be used to find a common marker across tumor types that could become a screening tool for a cancer that may not have many effective screening tools.



Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System discusses the benefits of liquid biopsy.

By dissecting the tumor molecularly and cellularly it can be determined what makes that tumor unique. Those unique factors can then be followed in the blood or the urine, providing critical information without going back into the tumor, says Miller.

This makes it easier to tell if the tumor is responding, allowing changes in treatment to be made right away if it is not. Liquid biopsy can also be used to find a common marker across tumor types that could become a screening tool for a cancer that may not have many effective screening tools.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x